Mesotelencephalic dopamine neurochemical responses to glucocorticoid administration and adrenalectomy in Fischer 344 and Lewis rats

Brain Research

Volumn 958, Issue 2, 2002, Pages 414-422

  Lindley, Steven E ^a,b   Bengoechea, Tasha G ^b   Wong, Dona L ^c   Schatzberg, Alan F ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Dopamine; Glucocorticoid; Medial prefrontal cortex; Nucleus accumbens; Striatum; Tyrosine hydroxylase

Indexed keywords

CORTICOSTERONE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; GLUCOCORTICOID; HOMOVANILLIC ACID; OXYGENASE; PLACEBO; TYROSINE 3 MONOOXYGENASE;

ADRENALECTOMY; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; MALE; METABOLITE; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN CONTENT; RAT STRAIN; TELENCEPHALON; VENTRAL TEGMENTUM;

ADMINISTRATION, CUTANEOUS; ADRENALECTOMY; ANIMALS; CORTICOSTERONE; DOPAMINE; DRUG IMPLANTS; MESENCEPHALON; RATS; RATS, INBRED F344; RATS, INBRED LEW; TELENCEPHALON;

EID: 0037184678     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03719-8     Document Type: Article

References (66)

1. Acquas E., Carboni E., de Ree R.H., Da Prada M., Di Chiara G. Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592. J. Neurochem. 59:1992;326-330.
2. Armario A., Gavalda A., Marti J. Comparison of the behavioural and endocrine response to forced swimming stress in five inbred strains of rats. Psychoneuroendocrinology. 20:1995;879-890.
3. Barrot M., Marinelli M., Abrous D.N., Rouge-Pont F., Le Moal M., Piazza P.V. The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent. Eur. J. Neurosci. 12:2000;973-979.
4. Beitner-Johnson D., Guitart X., Nestler E.J. Dopaminergic brain reward regions of Lewis and Fischer rats display different levels of tyrosine hydroxylase and other morphine- and cocaine-regulated phosphoproteins. Brain Res. 561:1991;147-150.
5. Beitner-Johnson D., Guitart X., Nestler E.J. Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area. J. Neurochem. 61:1993;1766-1773.
6. Brannan T., Prikhojan A., Yahr M.D. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism. J. Neural Transm. 104:1997;77-87.
7. Budygin E.A., Gainetdinov R.R., Kilpatrick M.R., Rayevsky K.S., Mannisto P.T., Wightman R.M. Effect of tolcapone, a catechol-O-methyltransferase inhibitor, on striatal dopaminergic transmission during blockade of dopamine uptake. Eur. J. Pharmacol. 370:1999;125-131.
8. Cador M., Dulluc J., Mormede P. Modulation of the locomotor response to amphetamine by corticosterone. Neuroscience. 56:1993;981-988.
9. Caesar P.M., Collins G.G., Sandler M. Catecholamine metabolism and monoamine oxidase activity in adrenalectomized rats. Biochem. Pharmacol. 19:1970;921-926.
10. Cools A.R., Peeters B.W. Differences in spike-wave discharges in two rat selection lines characterized by opposite dopaminergic activities. Neurosci. Lett. 134:1992;253-256.
11. Cooper J.R., Bloom F.E., Roth R.H. The Biochemical Basis of Neuropharmacology. 6th Edition :1991;220-284 Oxford University Press, Inc, New York.
12. Cyr M., Morissette M., Barden N., Beaulieu S., Rochford J., Di Paolo T. Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effects of antidepressants. Neuroscience. 102:2001;151-158.
13. Deutch A.Y., Cameron D.S. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience. 46:1992;49-56.
14. Dhabhar F.S., McEwen B.S., Spencer R.L. Adaptation to prolonged or repeated stress-comparison between rat strains showing intrinsic differences in reactivity to acute stress. Neuroendocrinology. 65:1997;360-368.
15. Dinan T.G. Noradrenergic and serotonergic abnormalities in depression: stress-induced dysfunction. J. Clin. Psychiatry. 57:1996;14-18. Suppl. 4.
16. Dunn A.J. Stress-related changes in cerebral catecholamine and indoleamine metabolism: lack of effect of adrenalectomy and corticosterone. J. Neurochem. 51:1988;406-412.
17. Dunn A.J. Footshock-induced changes in brain catecholamines and indoleamines are not mediated by CRF or ACTH. Neurochem. Int. 37:2000;61-69.
18. Faunt J.E., Crocker A.D. Adrenocortical hormone status affects responses to dopamine receptor agonists. Eur. J. Pharmacol. 152:1988;255-261.
19. Gilad G.M., Rabey J.M., Gilad V.H. Presynaptic effects of glucocorticoids on dopaminergic and cholinergic synaptosomes. Implications for rapid endocrine-neural interactions in stress. Life Sci. 40:1987;2401-2408.
20. Gomez F., De Kloet E.R., Armario A. Glucocorticoid negative feedback on the HPA axis in five inbred rat strains. Am. J. Physiol. 274:1998;R420-427.
21. Guitart X., Lumeng L., Li T.K., Nestler E.J. Alcohol-preferring and nonpreferring rats display different levels of neurofilament proteins in the ventral tegmental are. Alcohol Clin. Exp. Res. 17:1993;580-585.
22. Hurd Y.L., Ungerstedt U. In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur. J. Pharmacol. 166:1989;251-260.
23. Imperato A., Puglisi-Allegra S., Casolini P., Zocchi A., Angelucci L. Stress-induced enhancement of dopamine and acetylcholine release in limbic structures: role of corticosterone. Eur. J. Pharmacol. 165:1989;337-338.
24. Inoue T., Koyama T. Effects of acute and chronic administration of high-dose corticosterone and dexamethasone on regional brain dopamine and serotonin metabolism in rats. Prog. Neuropsychopharmacol. Biol. Psychiat. 20:1996;147-156.
25. Justice J.B. Jr. Quantitative microdialysis of neurotransmitters. J. Neurosci. Meth. 48:1993;263-276.
26. Karalis K., Crofford L., Wilder R., Chrousos G. Glucocorticoid and/or glucocorticoid antagonist effects in inflammatory disease-susceptible Lewis rats and inflammatory disease-resistant Fischer rats. Endocrinology. 136:1995;3107-3112.
27. Karoum F., Chrapusta S.J., Brinjak R., Hitri A., Wyatt R.J. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain. Br. J. Pharmacol. 113:1994;1391-1399.
28. Lindley S.E., Bengoechea T.G., Schatzberg A.F., Wong D.L. Glucocorticoid effects on mesotelencephalic dopamine neurotransmission. Neuropsychopharmacology. 21:1999;399-407.
29. Lindley S.E., Bengoechea T.G., Wong D.L., Schatzberg A.F. Strain differences in mesotelencephalic dopaminergic neuronal regulation between Fischer 344 and Lewis rats. Brain Res. 832:1999;152-158.
30. Lindley S.E., Lookingland K.J., Moore K.E. Activation of tuberoinfundibular but not tuberohypophysial dopaminergic neurons following intracerebroventricular administration of alpha-melanocyte-stimulating hormone. Neuroendocrinology. 51:1990;394-399. published erratum appears in Neuroendocrinology 1990 Aug;52(2):following 211.
31. Marinelli M., Piazza P.V., Deroche V., Maccari S., Le Moal M., Simon H. Corticosterone circadian secretion differentially facilitates dopamine-mediated psychomotor effect of cocaine and morphine. J. Neurosci. 14:1994;2724-2731.
32. Markey K.A., Sze P.Y. Influence of ACTH on tyrosine hydroxylase activity in the locus coeruleus of mouse brain. Neuroendocrinology. 38:1984;269-275.
33. McEwen B.S. Stress, adaptation, and disease. Allostasis and allostatic load. Ann. NY Acad. Sci. 840:1998;33-44.
34. Meyer J.S. Biochemical effects of corticosteroids on neural tissues. Physiol. Rev. 65:1985;946-1020.
35. Nakachi N., Kiuchi Y., Inagaki M., Inazu M., Yamazaki Y., Oguchi K. Effects of various dopamine uptake inhibitors on striatal extracellular dopamine levels and behaviours in rats. Eur. J. Pharmacol. 281:1995;195-203.
36. Nemeroff C.B. The Psychoneuroendocrinology of Depression: Hypothalamic-Pituitary Adrenal Axis Dysregulation. Strecker Monograph Series. 30:1993;1-36.
37. Nissbrandt H., Engberg G., Pileblad E. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra. Naunyn Schmiedebergs Arch. Pharmacol. 344:1991;16-28.
38. Ortiz J., De Caprio J.L., Kosten T.A., Nestler E.J. Strain-selective effects of corticosterone on locomotor sensitization to cocaine and on levels of tyrosine hydroxylase and glucocorticoid receptor in the ventral tegmental area. Neuroscience. 67:1995;383-397.
39. Palkovits M. Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res. 59:1973;449-450.
40. Parsons L.H., Justice J.B.J.r. Quantitative approaches to in vivo brain microdialysis. Crit. Rev. Neurobiol. 8:1994;189-220.
41. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates 3rd Edition, Academic Press, Inc., San Diego, 1997.
42. Piazza P.V., Barrot M., Rouge-Pont F., et al. Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission. Proc. Natl. Acad. Sci. USA. 93:1996;15445-15450.
43. Piazza P.V., Deroche V., Deminiere J.M., Maccari S., Le Moal M., Simon H. Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors. Proc. Natl. Acad. Sci. USA. 90:1993;11738-11742.
44. Piazza P.V., Le Moal M. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu. Rev. Pharmacol. Toxicol. 36:1996;359-378.
45. Piazza P.V., Rouge-Pont F., Deroche V., Maccari S., Simon H., Le Moal M. Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc. Natl. Acad. Sci. USA. 93:1996;8716-8720.
46. Reith M.E., Li M.Y., Yan Q.S. Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers. Psychopharmacology (Berl). 134:1997;309-317.
47. Rex A., Sondern U., Voigt J.P., Franck S., Fink H. Strain differences in fear-motivated behavior of rats. Pharmacol. Biochem. Behav. 54:1996;107-111.
48. Rivet J.M., Stinus L., LeMoal M., Mormede P. Behavioral sensitization to amphetamine is dependent on corticosteroid receptor activation. Brain Res. 498:1989;149-153.
49. Roth R.H., Murrin L.C., Walters J.R. Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid. Eur. J. Pharmacol. 36:1976;163-171.
50. Rothschild A.J., Langlais P.J., Schatzberg A.F., et al. The effects of a single acute dose of dexamethasone on monoamine and metabolite levels in rat brain. Life Sci. 36:1985;2491-2501.
51. Rouge-Pont F., Deroche V., Le Moal M., Piazza P.V. Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone. Eur. J. Neurosci. 10:1998;3903-3907.
52. Sarnyal Z., McKittrick C.R., McEwen B.S., Kreek M.J. Selective regulation of dopamine transporter binding in the shell of the nucleus accumbens by adrenalectomy and corticosterone-replacement. Synapse. 30:1998;334-337.
53. Schatzberg A.F., Rothschild A.J. The roles of glucocorticoid and dopaminergic systems in delusional (psychotic) depression. Ann. NY Acad. Sci. 537:1988;462-471.
54. Schatzberg A.F., Rothschild A.J., Langlais P.J., Bird E.D., Cole J.O. A corticosteroid/dopamine hypothesis for psychotic depression and related states. J. Psychiatr. Res. 19:1985;57-64.
55. Shurin M.R., Kusnecov A.W., Riechman S.E., Rabin B.S. Effect of a conditioned aversive stimulus on the immune response in three strains of rats. Psychoneuroendocrinology. 20:1995;837-849.
56. Simar M.R., Saphier D., Goeders N.E. Dexamethasone suppression of the effects of cocaine on adrenocortical secretion in Lewis and Fischer rats. Psychoneuroendocrinology. 22:1997;141-153.
57. Smith C.C., Omeljaniuk R.J., Whitfield H.J. Jr. Differential mineralocorticoid (type 1) and glucocorticoid (type 2) receptor expression in Lewis and Fischer rats. Neuroimmunomodulation. 1:1994;66-73.
58. Smith M.A., Brady L.S., Glowa J., Gold P.W., Herkenham M. Effects of stress and adrenalectomy on tyrosine hydroxylase mRNA levels in the locus ceruleus by in situ hybridization. Brain Res. 544:1991;26-32.
59. Stachowiak M.K., Rigual R.J., Lee P.H., Viveros O.H., Hong J.S. Regulation of tyrosine hydroxylase and phenylethanolamine N-methyltransferase mRNA levels in the sympathoadrenal system by the pituitary-adrenocortical axis. Brain Res. 427:1988;275-286.
60. Tanganelli S., Fuxe K., von Euler G., Eneroth P., Agnati L.F., Ungerstedt U. Changes in pituitary-adrenal activity affect the apomorphine- and cholecystokinin-8-induced changes in striatal dopamine release using microdialysis. J. Neural Transm. Gen. Sect. 81:1990;183-194.
61. Tuomainen P., Tornwall M., Mannisto P.T. Minor effect of tolcapone, a catechol-O-methyltransferase inhibitor, on extracellular dopamine levels modified by amphetamine or pargyline: a microdialysis study in anaesthetized rats. Pharmacol. Toxicol. 78:1996;392-396.
62. Van Loon G.R., Sole M.J., Kamble A., Kim C., Green S. Differential responsiveness of central noradrenergic and dopaminergic neuron tyrosine hydroxylase to hypophysectomy. ACTH and glucocorticoid administration. Ann. NY Acad. Sci. 297:1977;284-294.
63. Veals J.W., Korduba C.A., Symchowicz S. Effect of dexamethasone on monoamine oxidase inhibiton by iproniazid in rat brain. Eur. J. Pharmacol. 41:1977;291-299.
64. Windle R.J., Wood S.A., Lightman S.L., Ingram C.D. The pulsatile characteristics of hypothalamo-pituitary-adrenal activity in female Lewis and Fischer 344 rats and its relationship to differential stress responses. Endocrinology. 139:1998;4044-4052.
65. Wolkowitz O., Sutton M., Koulu M., et al. Chronic corticosterone administration in rats: behavioral and biochemical evidence of increased central dopaminergic activity. Eur. J. Pharmacol. 122:1986;329-338.
66. Wolkowitz O.M. Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology. 19:1994;233-255.